Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Impact of sepsis on circulating exosomes: pathophysiological mechanisms, biomarker potential, and therapeutic applications

Wu SC., Rau CS., Hsieh CH.

Narrative Review on Chronic Inflammation, published in Int J Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Surg (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40787977
PMCID
PMC12695378
DOI
10.1097/js9.0000000000003129

Abstract (original English)

This comprehensive review examines the complex interplay between sepsis and circulating exosomes. Sepsis, characterized by dysregulated host response to infection leading to life-threatening organ dysfunction, remains a significant global health challenge with high mortality rates. Exosomes, small extracellular vesicles (30-150 nm) released by most cell types, play crucial roles in intercellular communication by transferring bioactive molecules. During sepsis, both exosome quantity and cargo composition undergo significant alterations, reflecting the host's pathophysiological state. The review explores how sepsis-induced inflammation influences exosome biogenesis and content, including proteins, microRNAs, and other non-coding RNAs. These modified exosomes can propagate inflammatory signals throughout the body while also participating in immunosuppressive mechanisms characteristic of later sepsis stages. The potential of exosomes as diagnostic and prognostic biomarkers is highlighted, with specific exosomal components correlating with disease severity and organ dysfunction. Additionally, emerging therapeutic strategies targeting exosomes or utilizing them as delivery vehicles for anti-inflammatory agents are discussed. By consolidating recent findings, this review underscores the significance of exosome research in advancing our understanding of sepsis pathophysiology and devel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansSepsisInflammationMicroRNAsExosomesBiomarkers

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research